Skip to content
thispeptide

Nucore Health

Nucore combines GLP care with separate wellness products. Its NAD page distinguishes biological research from treatment evidence, while actual prescriber, pharmacy and monitoring details need confirmation.

Review by Molly Ward, goal-guide writer · Updated October 2026

The short version

Evaluate the actual treatment pathway rather than a general wellness promise. The NAD evidence qualifications help, but they do not replace the assigned practitioner and pharmacy information.

Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Nucore Technologies LLC operates Nucore Health as a remote-care platform. Current pages identify compounded semaglutide, tirzepatide and several separate wellness products. The published agreements distinguish the platform from independent medical and pharmacy services. Those products require different assessment, administration and monitoring decisions.

What Nucore Health prescribes, by goal

Weight

  • SemaglutideFDA-approved

    Listed by the seller; no price we hold.

    • TirzepatideFDA-approved

      Listed by the seller; no price we hold.

      The GLP page identifies compounded ingredients and a separate oral semaglutide option. A format label does not establish equivalence to a particular approved product. The microdosing pathway also requires individual assessment; a smaller dose or testimonial does not prove a superior result for every patient.

      Longevity

      • NAD+Compounding conditions apply
        • Injection (compounded)Price not published
        • Nasal spray (compounded)Price not published
        • Oral (compounded)Price not published
      • GlutathioneCompounding conditions apply

        Listed by the seller; no price we hold.

        The NAD page distinguishes cellular biology from evidence about the offered formulations. It explains that research involving NMN, a different precursor, does not establish benefits from these NAD+ products. It also acknowledges uncertain benefits and timelines. That qualification is more informative than assuming every wellness formulation reverses aging.

        Recovery

        • SermorelinCompounding conditions apply

          Listed by the seller; no price we hold.

          Sleep

          • SermorelinCompounding conditions apply

            Listed by the seller; no price we hold.

            Who prescribes

            A licensed clinician

            The public treatment and legal description does not name the individual prescriber or medical director. OpenLoop Health is identified as a technology and operational partner. That reference alone does not identify the practitioner assigned to a prescription. Ask who evaluates your history and retains responsibility for continuing treatment.

            The NAD pathway uses a questionnaire followed by purchase and clinical review. A phone or video visit is not mentioned as required; the page expressly describes asynchronous prescribing. Other services may use different arrangements under the telehealth consent. Confirm which assessment and follow-up contacts apply to the product you select.

            Are labs required?

            Not mentioned

            The GLP guidance requests updated weight, blood pressure and heart rate information before visits. A universal laboratory panel, included testing amount and reassessment interval are not established for every treatment. Ask which measurements or tests the clinician needs and how abnormal results affect continued prescribing.

            Ready to start with Nucore Health?

            Prices and plans are set on the seller's own site.

            What it claims, and what it cites

            The NAD material offers injection, nasal and oral options while separating those prescriptions from general biological findings. It acknowledges that compounded products are not FDA-approved. A separate wellness overview makes broader benefit claims, so assess the evidence for the actual formulation. Marketing categories should not substitute for a treatment-specific discussion of risks and uncertainty.

            Other products and treatment claims

            A recurring NAD price from the introductory offer
            The first-month code does not establish which options qualify or the subsequent prescription charge.

            How it bills

            The GLP page shows starting amounts of $179 for compounded semaglutide and $269 for compounded tirzepatide. Separate oral and microdosing offers use other figures. NAD’s $99 promotion applies only to the first month. General thirty- or ninety-day renewal language does not settle every selected product’s ongoing billing clock.

            For and against

            • For: Separate NAD biology and treatment-evidence discussion
            • For: Asynchronous NAD assessment clearly described
            • For: Compounded-product limitations acknowledged
            • For: Care responsibilities distinguished in published agreements
            • Against: Individual prescriber not publicly named
            • Against: Actual dispensing pharmacy unresolved
            • Against: Universal laboratory plan not specified
            • Against: Introductory and recurring offers need product-specific quotes

            The evidence behind what it sells

            Right for

            A patient comparing the actual preparation and evidence limits while obtaining a clear assessment and monitoring plan.

            Look elsewhere if

            Someone interpreting precursor research, a low introductory amount or a wellness category as proof of a treatment benefit.

            Other sellers for weight

            Nucore Health

            Frequently asked questions

            Does the NAD page equate NMN studies with proof for its treatments?
            No. It distinguishes the different precursor and explains limits in applying those findings to the offered NAD+ options.
            Is a live appointment required for the described NAD pathway?
            The page describes asynchronous intake, purchase and provider review without a required phone or video appointment.
            Does a general platform partner identify the treating practitioner?
            No. Confirm the individual clinician and actual dispensing pharmacy before relying on a continuing prescription plan.

            Sources

            • Current ingredient-specific GLP offers and program context
            • Microdosing introduction and required purchase term
            • NAD routes, introductory offer and evidence limitations
            • Care model and current service availability
            • Operator and separate clinical responsibilities
            • Telehealth modalities and provider independence
            • Cancellation deadlines and prepared-order refund limits
            • Separate wellness treatment menu

            See what Nucore Health prescribes today

            Nucore Health sets its own prices, plans and the states it serves. Check them before you start.

            Written by Molly Ward from Nucore Health’s own public pages, against the published methodology. No outcome is claimed first-hand and no score is given. A partnership never changes what this page says; see how the site is paid.